Publicacións en colaboración con investigadores/as de Hospital General Universitario de Elche (2)

2024

  1. Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study

    ESMO Open, Vol. 9, Núm. 9

2013

  1. Therapy management with sunitinib in patients with metastatic renal cell carcinoma: Key concepts and the impact of clinical biomarkers

    Cancer Treatment Reviews, Vol. 39, Núm. 3, pp. 230-240